Dr. Juckett

Dr. Mark Juckett named Masonic Cancer Center CTO-CGI Medical Director

April 15, 2021 - Mark Juckett, MD, Professor of Medicine, Division of Hematology, Oncology, and Transplantation (HOT) of the University of Minnesota Medical School, was appointed Medical Director of the Masonic Cancer Center Clinical Trials Office for the Cellular, Gene and Immunotherapy Initiative (CTO-CGI), succeeding Dr. Shernan Holtan who initiated the role.

“I am extremely happy to welcome Dr. Juckett to the Masonic Cancer Center as our new CTO-CGI Medical Director,” said John Wagner, MD, Director of the Institute of Cell, Gene, and Immunotherapy and Co-Associate Director for Clinical Research at the Masonic Cancer Center. “Cell-based treatments and immunotherapies are increasingly complex, often with complicated manufacturing schemes, and require new modes of delivery and patient care monitoring requirements. We are leaders in this area, and we need specialized teams managing the entire process from trial inception through conduct and reporting of results. Dr. Juckett’s experience in not only clinical trials but also in cellular therapies will be instrumental to the next phase of the CTO-CGI’s development. ”

Dr. Juckett was recruited from the University of Wisconsin - Madison where he was Vice Chair for Clinical Affairs and Quality for the Department of Medicine, the Director of the Hematology/Bone Marrow Transplant Clinical Research Program, and the Director of the Bone Marrow Transplant Program at the UW Carbone Cancer Center.

He is board-certified in hematology and medical oncology with areas of expertise in acute leukemia, myelodysplastic syndromes, myeloproliferative neoplasms, bone marrow transplantation and cellular therapy, graft-vs-host disease, and cancer survivorship.

“I am thrilled to return to the University of Minnesota to join a remarkably productive team of investigators in the realm of cell-based therapy,” Dr. Juckett said. “The University is recognized as a world leader in the development of these innovative therapies. I’m grateful to join a team devoted to bringing these cutting-edge options to people as efficiently and compassionately as possible.”

Dr. Juckett is an active member of the American Society of Hematology, American Society of Transplantation and Cellular Therapy, and the Center for International Blood and Marrow Transplant Research and a winner of America’s Top Doctors in Cancer and Best Doctors in America annually since 2010.  

Dr. Juckett graduated from the University of Louisville School of Medicine in 1987 and was previously with the University of Minnesota for his residency and fellowship training. He spent 20 years at the University of Wisconsin-Madison and the Carbone Cancer Center before joining the Masonic Cancer Center and the HOT Division of the University of Minnesota Medical School in February 2021.

About the Masonic Cancer Center

The Masonic Cancer Center, University of Minnesota, is the Twin Cities’ only Comprehensive Cancer Center, designated ‘Outstanding’ by the National Cancer Institute. As Minnesota’s Cancer Center, we have served the entire state for more than 25 years. Our researchers, educators, and care providers have worked to discover the causes, prevention, detection, and treatment of cancer and cancer-related diseases. Learn more at cancer.umn.edu.